Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suma Babu

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
JAMA Neurology|February 9, 2026
Long-Term Tofersen in SOD1 Amyotrophic Lateral SclerosisTimothy M Miller, Merit E Cudkowicz, Pamela J Shaw, et al.
Muscle & Nerve|May 27, 2025
Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform TrialBrittney A Harkey, Sofia Distefano, Jaclyn A Pagliaro, et al.
Muscle & Nerve|December 19, 2022
Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocolDario Gelevski, Grace Addy, Margot Rohrer, et al.
The Lancet. Neurology|July 26, 2024
Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose studyLeonard H van den Berg, Jeffrey D Rothstein, Pamela J Shaw, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 28, 2018
Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centresChristoph Neuwirth, Nathalie Braun, Kristl G Claeys, et al.
Muscle & Nerve|June 6, 2024
Multicenter expanded access program for access to investigational products for amyotrophic lateral sclerosisDylan V Neel, Clara Baselga-Garriga, Molly Benson, et al.
JAMA Neurology|July 6, 2026
Antisense Oligonucleotide Tofersen Distribution in the Central Nervous System of SOD1-ALS Autopsy Tissue DonorsAmanda J Guise, Monica Thanawala Sellon, Shanu F Roemer, et al.
Muscle & Nerve|August 26, 2025
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral SclerosisBrooke Krivickas, Erica Scirocco, Elisa Giacomelli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
The New England Journal of Medicine|September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
JAMA Neurology|February 9, 2026
Long-Term Tofersen in SOD1 Amyotrophic Lateral SclerosisTimothy M Miller, Merit E Cudkowicz, Pamela J Shaw, et al.
Muscle & Nerve|May 27, 2025
Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform TrialBrittney A Harkey, Sofia Distefano, Jaclyn A Pagliaro, et al.
Muscle & Nerve|December 19, 2022
Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocolDario Gelevski, Grace Addy, Margot Rohrer, et al.
The Lancet. Neurology|July 26, 2024
Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose studyLeonard H van den Berg, Jeffrey D Rothstein, Pamela J Shaw, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 28, 2018
Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centresChristoph Neuwirth, Nathalie Braun, Kristl G Claeys, et al.
Muscle & Nerve|June 6, 2024
Multicenter expanded access program for access to investigational products for amyotrophic lateral sclerosisDylan V Neel, Clara Baselga-Garriga, Molly Benson, et al.
JAMA Neurology|July 6, 2026
Antisense Oligonucleotide Tofersen Distribution in the Central Nervous System of SOD1-ALS Autopsy Tissue DonorsAmanda J Guise, Monica Thanawala Sellon, Shanu F Roemer, et al.
Muscle & Nerve|August 26, 2025
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral SclerosisBrooke Krivickas, Erica Scirocco, Elisa Giacomelli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2022
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trialSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
The New England Journal of Medicine|September 3, 2020
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Eric A Macklin, Suzanne Hendrix, et al.
Pageof 6